Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-intensity Atorvastatin in STEMI patients undergoing PPCI
NCT04754789Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Feb 2021
- Primary completion
- Mar 2021
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of atorvastatin in ST-elevation myocardial infarction (STEMI) (2 arms), sponsored by Assiut University. Primary endpoint: Laboratory investigation at 3 months. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
ST-elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT04754789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04754789.